Walleye Capital’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.66M Buy
+67,900
New +$3.86M 0.02% 867
2026
Q1
Sell
-14,787
Closed -$1.92M 5049
2025
Q4
$1.92M Buy
14,787
+6,951
+89% +$954K 0.01% 1903
2025
Q3
$844K Buy
+7,836
New +$854K ﹤0.01% 2223
2022
Q3
Sell
-314
Closed -$13K 3585
2022
Q2
$13K Buy
+314
New +$21.3K ﹤0.01% 1973
2021
Q1
Sell
-664
Closed -$242K 1366
2020
Q4
$242K Buy
+664
New +$231K 0.02% 677

Other funds holding WGS

Walleye Capital's WGS Position: Q2 2026 in Review

Walleye Capital opened a new position in GeneDx Holdings (WGS) in Q2 2026: 67,900 shares worth $4.66M. The stake represents 0.02% of the portfolio and ranks #867 among its holdings. This is a return to the name: Walleye Capital previously reported a position in WGS as recently as Q4 2025.

Walleye Capital first reported a position in WGS in Q4 2020 and has held it in 5 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Walleye Capital held 67,900 shares of GeneDx Holdings worth $4.66M as of Q2 2026.
  • GeneDx Holdings was a new Walleye Capital position in Q2 2026.
  • GeneDx Holdings made up 0.02% of Walleye Capital's portfolio in Q2 2026, its #867 holding.
  • Walleye Capital first reported a position in GeneDx Holdings in Q4 2020 and has held it in 5 quarters since.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.